Showing 33,261 - 33,280 results of 226,652 for search '(( a ((((mean decrease) OR (a decrease))) OR (linear decrease)) ) OR ( i largest decrease ))', query time: 2.08s Refine Results
  1. 33261

    DataSheet_1_Novel Isoquinoline Alkaloid Litcubanine A - A Potential Anti-Inflammatory Candidate.doc by Huan Xia (397709)

    Published 2021
    “…<p>Macrophages play a critical role in innate and adaptive immunity, and the regulation of macrophage function in inflammatory disease treatment has been widely studied. …”
  2. 33262

    Population Genetic Differences along a Latitudinal Cline between Original and Recently Colonized Habitat in a Butterfly by Sofie Vandewoestijne (238241)

    Published 2010
    “…A general decrease in genetic diversity with latitude was detected, likely due to post-glacial colonization effects. …”
  3. 33263

    Proposed model of a signaling cascade in which NPC plays a key role in root and nodule development. by Ronal Pacheco (10684467)

    Published 2025
    “…This would provoke a decrease in root development. Our results indicated that <i>PvASL18b</i> is involved in this mechanism. …”
  4. 33264

    Impact of fee subsidy policy on perinatal health in a low-resource setting: A quasi-experimental study by Ivlabèhiré Bertrand Meda (5946374)

    Published 2018
    “…There was no evidence of a significant decrease in neonatal mortality rates.…”
  5. 33265
  6. 33266
  7. 33267
  8. 33268
  9. 33269
  10. 33270
  11. 33271

    The cortical state is a tunable continuum. by Shree Hari Gautam (308739)

    Published 2015
    “…<p><b>(a)</b> Example MUA spike count time series during ongoing activity for unaltered inhibition (black), enhanced inhibition (blue), reduced inhibition (red). …”
  12. 33272
  13. 33273

    Image_3_Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression.JPEG by Sara J. Fagen (16810449)

    Published 2023
    “…Decreasing αsyn expression is recognized as a valid target for PD therapeutics, with down-regulation of SNCA expression potentially attenuating downstream cascades of pathologic events. …”
  14. 33274

    Table_1_Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression.docx by Sara J. Fagen (16810449)

    Published 2023
    “…Decreasing αsyn expression is recognized as a valid target for PD therapeutics, with down-regulation of SNCA expression potentially attenuating downstream cascades of pathologic events. …”
  15. 33275

    Table_2_Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression.DOCX by Sara J. Fagen (16810449)

    Published 2023
    “…Decreasing αsyn expression is recognized as a valid target for PD therapeutics, with down-regulation of SNCA expression potentially attenuating downstream cascades of pathologic events. …”
  16. 33276

    Image_1_Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression.JPEG by Sara J. Fagen (16810449)

    Published 2023
    “…Decreasing αsyn expression is recognized as a valid target for PD therapeutics, with down-regulation of SNCA expression potentially attenuating downstream cascades of pathologic events. …”
  17. 33277

    Image_2_Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression.JPEG by Sara J. Fagen (16810449)

    Published 2023
    “…Decreasing αsyn expression is recognized as a valid target for PD therapeutics, with down-regulation of SNCA expression potentially attenuating downstream cascades of pathologic events. …”
  18. 33278
  19. 33279

    The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress by Jun Wang (5906)

    Published 2015
    “…We conclude that ATWLPPR, an NRP-1 inhibitor, may reduce the early retinal damage induced by diabetes by preserving vascular integrity and decreasing the oxidative stress level. Blockade of NRP-1 may be a new therapeutic strategy for the early stages of DR.…”
  20. 33280